Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Donald P. Quick"'
Publikováno v:
Proc (Bayl Univ Med Cent)
Primary ambulatory thromboprophylaxis (PATP) in patients with solid malignancies is not routinely indicated. We performed a meta-analysis of randomized controlled trials (RCTs) to determine the benefit and risk of PATP in patients with nonpancreatic
Autor:
Donald P. Quick, David S. Siegel, Kevin W. Song, Siddhartha Ganguly, Jeffrey Matous, Weiyuan Chung, Gustavo Fonseca, Nizar J. Bahlis, Giampaolo Talamo, William E. Pierceall, Jesus G. Berdeja, Michael Bar, Christy J. Samaras, Christopher S. Seet, Michael Sebag, Gary J. Schiller, Mirelis Acosta-Rivera, Donna E. Reece, Amit Agarwal, Bertrand Anz, Faiza Zafar
Publikováno v:
Leukemia
Leukemia, vol 34, iss 12
Leukemia, vol 34, iss 12
Patients with multiple myeloma who have relapsed after or become refractory to lenalidomide in early treatment lines represent a clinically important population in need of effective therapies. The safety and efficacy of pomalidomide, low-dose dexamet
Publikováno v:
Thrombosis Research. 196:75-77
Autor:
Pau Montesinos, Farhad Ravandi, Martha Arellano, Karen Seiter, Ellin Berman, Jessica K. Altman, Lori J. Maness, Donald P. Quick, Parameswaran Venugopal, Judy H. Chiao, Scott R. Solomon, Rakesh Gaur, Mikkael A. Sekeres, Maria R. Baer, Marc Buyse, Aleksandra Butrym, David A. Rizzieri, Stephen A. Strickland, Stuart L. Goldberg, Tapan M. Kadia, Marc Gautier, David F. Claxton, Gary J. Schiller, Gianluca Gaidano, Kebede H. Begna, Selina M. Luger, Hagop M. Kantarjian, Xavier Thomas
Publikováno v:
Cancer
CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Cancer, vol 127, iss 23
CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Cancer, vol 127, iss 23
BackgroundAcute myeloid leukemia (AML) is fatal in elderly patients who are unfit for standard induction chemotherapy. The objective of this study was to evaluate the survival benefit of administering sapacitabine, an oral nucleoside analogue, in alt
Autor:
Zayar M. Oo, Miguel Quirch, Nyein H. Yu, Donald P. Quick, Sriman Swarup, Kyaw Zin Thein, Anita Sultan, Wai Lin Thein, Myo H. Zaw
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:EPR19-071
Background: Bruton’s tyrosine kinase (BTK) is essential for signaling of B-cell and chemokine receptors. Ibrutinib targets BTK and has become frontier in many hematologic malignancies. We undertook systematic review and pooled analysis of randomize
Autor:
Donald P. Quick, Seshadri Thirumala, Sriman Swarup, Kaiser Tarafdar, Jonathan Kopel, Kyaw Zin Thein, Khatrina Swarup
Publikováno v:
The American Journal of the Medical Sciences
In this case report of a patient with angioimmunoblastic T-cell lymphoma (AITL), we describe the occurrence of three sequential complications that have been reported uncommonly in this disease subtype. Firstly, the patient developed hypercalcemia due
Publikováno v:
Lung. 198(3)
Lung cancer (LC) is the leading cause of cancer mortality. PATP was provided in experimental trials to decrease the venous thromboembolism (VTE), with ultimate aim to improve overall survival (OS). We undertook an updated systematic review and meta-a
Autor:
Donna E. Reece, Amit Agarwal, Christopher S. Seet, Kevin W. Song, Michael Sebag, Prisca Vogel, David S. Siegel, Kim Lee, Siddhartha Ganguly, Gary J. Schiller, Mirelis Acosta-Rivera, Donald P. Quick, Nizar J. Bahlis, Jeffrey V. Matous, Jesus G. Berdeja, Michael Bar, Gustavo Fonseca, Bertrand Anz, Weiyuan Chung
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S141
Background Lenalidomide (LEN) with or without a proteasome inhibitor (PI) administered until disease progression is a standard treatment (Tx) approach for patients (pts) with newly diagnosed multiple myeloma (MM). Clinical trials investigating triple
Autor:
Weiyuan Chung, David S. Siegel, Bertrand Anz, Nizar J. Bahlis, Christopher S. Seet, Michael Sebag, Siddhartha Ganguly, Christy J. Samaras, Donna E. Reece, Amit Agarwal, Gustavo Fonseca, Jeffrey Matous, Mirelis Acosta-Rivera, Gary J. Schiller, Kevin W. Song, Kim Lee, Donald P. Quick, Jesus G. Berdeja, Michael Bar
Publikováno v:
Blood. 136:16-17
Introduction: Lenalidomide (LEN), a standard of care for newly diagnosed multiple myeloma, is routinely administered until disease progression. However, patients with disease that has relapsed after or become refractory to LEN have been poorly repres
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 30(4)
Calcium-binding at the A2 domain protects von Willebrand factor (VWF) from cleavage by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS13) and is coordinated by five important residues (p.Asp1596, p.Arg1597, p.Ala1600, p.Asn1602